Baxdrostat, Baxdrostat, Baxdrostat Placebo
D6974C00001
Phase 3 small_molecule active
Quick answer
Baxdrostat, Baxdrostat, Baxdrostat Placebo for Primary Aldosteronism defined by excess aldosterone secretion is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Primary Aldosteronism defined by excess aldosterone secretion
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active